A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute ...

Sickle cell disease is the most common inherited haemoglobinopathy in Tanzania, with 11 000– 14 000 children born with the ...

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a critical therapeutic strategy for treating conditions such as hematological ...

Madeleine R. Heldman, MD, MS, discusses managing cytomegalovirus, including advances in CMV assessment and antiviral and immune strategies.

A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBMT) ...

A novel regimen significantly reduced risk for moderate to severe chronic graft-versus-host disease for certain patients who ...

Immunosuppressive therapy improves pancytopenia in severe aplastic anemia.However, its effects are not long-lasting as evidenced by a modest 2-year EFS rate of just 46%, prompting the need for ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.